<DOC>
	<DOCNO>NCT01433900</DOCNO>
	<brief_summary>A 1-year prospective , randomize , investigator-masked trial compare confocal clinical effect treatment unpreserved prostaglandin ( tafluprost ) versus preserve prostaglandin ( latanoprost ) newly-diagnosed glaucoma patient .</brief_summary>
	<brief_title>Switching From Preserved Preserved-free Treatments Glaucoma .</brief_title>
	<detailed_description>The study protocol comprise 5 visit : baseline , month 3 , month 6 , month 9 , month 12 . At baseline clinical evaluator perform complete ophthalmologic evaluation confirm diagnosis . The following examination do follow sequence : anterior segment examination , Shirmer test , Break-up time test . Thereafter , confocal evaluator perform confocal microscopy central peripheral cornea . Finally , contact measurement do follow order : IOP ( measure 3 pm ) , pachimetry ( baseline visit ) gonioscony ( baseline visit ) . A 15 minute interval elapse two consecutive test .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>The patient suffer ocular hypertension , POAG , PEX , NTG . Glaucoma definition base European Glaucoma Society Guidelines . The patient newlydiagnosed No fluorescein stain baseline observable sign ocular surface disease No treatment topical BAKcontaining product least 6 month Treatment na√Øve patient Unwilling sign inform consent Not least 18 year old Ocular condition safety concern interfere study result Closed/barely open anterior chamber angle history acute angle closure . Ocular surgery argon laser trabeculoplasty within last year . Ocular inflammation/infection occur within three month prior pretrial visit . Presence follow ocular condition : KCS , moderatesevere blepharitis , Rosacea , Sjogren syndrome , pterygium , contact lens user . Use concomitant topical ocular medication interfere study medication Hypersensitivity benzalkonium chloride component trial drug solution . Any corneal pathology Diabetes stage Other abnormal condition symptom prevent patient enter trial , accord Investigator 's judgement . Refractive surgery patient Women pregnant , childbearing potential use adequate contraception nursing . Inability adhere treatment/visit plan . Have participate clinical trial ( i.e. , require inform consent ) within one three month prior pretrial visit ( depend ethic committee decision ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>intraocular pressure</keyword>
	<keyword>ocular surface</keyword>
	<keyword>benzalkonium chloride</keyword>
</DOC>